Podcasts about ckd

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for August 10-16, 2025: FDA Approves 2 Generic Iron Sucrose Injections for Iron Deficiency Anemia in CKD  The FDA approved 2 generic versions of iron sucrose injection for treating iron deficiency anemia in patients with CKD, expanding access to therapy. FDA Approves PharmaTher's Ketamine for Surgical Pain Management  The FDA approved PharmaTher's ketamine formulation for surgical pain management following resolution of earlier application deficiencies. HFSA and ASPC Release Statement on Shifting to Prevention in Heart Failure  The HFSA and ASPC issued a joint statement urging clinicians to prioritize prevention and early risk management in heart failure care. Zopapogene Imadenovec First Immunotherapy Approved for Recurrent Respiratory Papillomatosis  The FDA approved zopapogene imadenovec as the first immunotherapy for recurrent respiratory papillomatosis, offering a new treatment option. AHA & ACC Release New Guidelines for High Blood Pressure to Reduce CVD Risk  The AHA and ACC released updated hypertension guidelines recommending earlier intervention to lower cardiovascular disease risk.

Is high protein intake responsible for chronic kidney disease? Have you ever heard that ketogenic diets are harmful to your kidneys?These are just a few of the common kidney health myths debunked in this interview with Dr. Thomas Weimbs, who says that traditional views on what causes chronic kidney disease are “definitely not founded in science.”Dr. Thomas Weimbs, professor and vice chair at UC Santa Barbara, has spent decades studying chronic kidney disease (CKD). His recent research explores the impact of ketogenic interventions on kidney function, and the findings may surprise you. Rather than harming the kidneys, Dr. Weimbs is finding that keto can actually improve kidney function in people living with CKD.According to Dr. Weimbs, “Clearly, the number one cause of chronic kidney disease is not protein in excess—it's, of course, carbohydrates in excess and type 2 diabetes. Insulin resistance is causing chronic kidney disease.”In this episode, you'll learn:Why longstanding myths about protein and kidney function need to be re-examinedWhy misconceptions around keto and kidney health existHow ketogenic diets are showing promise for chronic kidney disease (including PKD)About results from randomized controlled trials and the 2-year Virta Health studyHow ketones may directly benefit kidney healthDr. Weimbs also shares insights from his lab's ongoing research—findings that challenge conventional thinking and call for a re-examination of how we understand and treat chronic kidney disease.Expert Featured:Dr. Thomas Weimbshttps://www.facebook.com/groups/256099897773551/https://santabarbaranutrients.com/CMEs Mentioned:Managing Major Mental Illness with Dietary Change: The New Science of Hopehttps://www.mycme.com/courses/managing-major-mental-illness-with-dietary-change-9616Brain Energy: The Metabolic Theory of Mental Illnesshttps://www.mycme.com/courses/brain-energy-the-metabolic-theory-of-mental-illness-9615Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry.Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/About us:Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them.Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications.

What does effective kidney care look like in the primary care setting—and who's really involved beyond your GP? In this first of a special two-part series, host Dee Moore is joined by Dr. Kristin Veighey to explore the crucial yet often misunderstood role of primary care in managing chronic kidney disease (CKD).   This episode takes you beyond the GP, highlighting the power of the multidisciplinary team—including specialist nurses, pharmacists, health coaches, social prescribers, and mental health professionals—and how each plays a unique role in supporting kidney health.   Together, they discuss: • The definition and purpose of primary care vs. secondary care • Why CKD is often overlooked or mismanaged in primary care settings • The impact of legacy thinking, outdated guidelines, and unclear care pathways • How to navigate the system, understand who does what, and advocate for yourself • The importance of tracking your eGFR, blood pressure, and asking the right questions during health checks   This empowering episode is designed to help you take control of your kidney health journey by understanding your rights, responsibilities, and the full range of support available to you.  

Join us on this episode of Nothing But The Truth as we sit down with the remarkable Juliette Ashley Valle, Miss Florida 2023! Juliette shares her inspiring journey through the world of beauty pageants and beyond, revealing how she's leveraged her platform to advocate for critical causes. More about Juliette: ▸ Miss Florida 2023: Made history as the second Hispanic titleholder and the first Miss America contestant to deliver a bilingual onstage Q&A, placing in the Top 10 nationally. ▸ Advocate for Kidney Health & Women's Empowerment: A National Ambassador for Donate Life America and the National Kidney Foundation, she founded "Rise Up, Latinas!" – a nonprofit focused on Latina leadership and mentorship. ▸ Dynamic Background: A law student, aspiring reporter, and professional performer with a B.A. from the University of Miami and current studies at St. Thomas University College of Law and Harvard University. ▸ Award-Winning Talent: Recognized with multiple preliminary competition awards, she's also a verified recording artist who donates album proceeds to CKD charities.

In this episode of the Xtalks Life Science Podcast, Ayesha Rashid speaks with Laura Williams, MD, MPH, chief patient officer at Ardelyx, a company developing and commercializing first-in-class medicines for diseases like chronic kidney disease (CKD) and irritable bowel syndrome (IBS). Dr. Williams brings nearly 30 years of experience in clinical development, drug strategy and patient advocacy. With leadership roles across big pharma and biotech — including Abbott, Myovant and AMAG Pharmaceuticals — her impact is marked by eight FDA drug approvals and a relentless focus on improving patient outcomes. Before joining Ardelyx, Dr. Williams was SVP and head of clinical development and biostatistics at AMAG Pharmaceuticals, overseeing four investigational assets and two marketed products. She previously served as VP of clinical development at Myovant Sciences and spent 18 years at Abbott/AbbVie, where she led global clinical programs and managed the general medicine therapeutic area. Dr. Williams received a Bachelor of Science degree from Mississippi State University, a Doctor of Medicine degree from University of Iowa and a Master of Public Health degree in epidemiology from University of Washington, where she also completed a clinical fellowship in infectious diseases. She completed her Internal Medicine residency at University of Michigan, where she also served as Chief Resident and Junior Faculty. Tune in as Dr. Williams shares how her unique blend of scientific expertise and deep commitment to the patient voice drives innovation at Ardelyx. She discusses the evolving, up-and-coming role of chief patient officer, key lessons learned, the challenges of patient-centric drug development and what's ahead in addressing critical unmet medical needs. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

On this week's episode, Eric Schmidt, Brad Loncar, Tim Opler and Tess Cameron kick off with a discussion on the surgein biotech M&A, with 2025 almost matching 2024's deal count and surpassing it in value ($40B YTD vs $30B), highlighting recent deals like Merck's acquisition of Verona and AbbVie's purchase of Capstan. The group debateswhether this signals a true “M&A wave,” noting pharma's $150 billion of LOE approaching and reduced macro uncertainty could be driving deal flow. They alsonote a current competitive dynamic around commercial-stage assets. Shifting to policy, Trump's “Big Beautiful Bill” introduces key IRA exemptions for rare diseases and on tariffs, the co-hosts note the market's quiet reaction andwonder if investors are becoming desensitized to D.C. headlines. As M&A steadies and drug launches hold strong despite pricing pressure, some stability seems to be on the way. On the regulatory front, the group praises the FDA'simproved communication under new leadership, citing their strong online presence and experience with media. Despite the FDA's recent rejection of Capricor's cell therapy for DMD, optimism remains about the therapy's potential. Despite the improved communication discussed earlier, questionsabout the FDA's transparency arise following the agency's issuance of CRLs to be more transparent; it remains uncertain if this trend will continue. Conversation shifts to data, overviewing KalVista's approval of Ekterly, thefirst oral calcineurin inhibitor approved for hereditary angioedema attacks and ProKidney's cell therapy that showed improved eGFR slope in CKD patients in aPhase 2 trial, skyrocketing shares. The episode closes with a conversation on obesity trends. *This episode aired on July 11, 2025. 

Episode 198: Fatigue.  Future doctors Redden and Ibrahim discuss with Dr. Arreaza the different causes of fatigue, including physical and mental illnesses. Dr. Arreaza describes the steps to evaluate fatigue. Some common misconceptions are explained, such as vitamin D deficiency and “chronic Lyme disease”. Written by Michael Ibrahim, MSIV, and Jordan Redden, MSIV, Ross University School of Medicine. Edits and comments by Hector Arreaza, MDYou are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Dr. Arreaza: Today is a great day to talk about fatigue. It is one of the most common and most complex complaints we see in primary care. It involves physical, mental, and emotional health. So today, we're walking through a case, breaking down causes, red flags, and how to work it up without ordering the entire lab catalog.Michael:Case: This is a 34-year-old female who comes in saying, "I've been feeling drained for the past 3 months." She says she's been sleeping 8 hours a night but still wakes up tired. No recent illnesses, no weight loss, fever, or night sweats. She denies depression or anxiety but does report a lot of work stress and taking care of her two little ones at home. She drinks 2 cups of coffee a day, doesn't drink alcohol, and doesn't use drugs. No medications, just a multivitamin. Regular menstrual cycles—but she's noticed they've been heavier recently.Jordan:Fatigue is a persistent sense of exhaustion that isn't relieved by rest. It's different from sleepiness or muscle weakness.Classification based on timeline:    •   Acute fatigue: less than 1 month    •   Subacute: 1 to 6 months    •   Chronic: more than 6 monthsThis patient's case is subacute—going on 3 months now.Dr. Arreaza:And we can think about fatigue in types:    •   Physical fatigue: like muscle tiredness after activity    •   Mental fatigue: trouble concentrating or thinking clearly (physical + mental when you are a medical student or resident)    •    Pathological fatigue: which isn't proportional to effort and doesn't get better with restAnd of course, there's chronic fatigue syndrome, also called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is a diagnosis of exclusion after 6 months of disabling fatigue with other symptoms.Michael:The differential is massive. So, we can also group it by systems.Jordan:Let's run through the big ones.Endocrine / Metabolic Causes    • Hypothyroidism: A classic cause of fatigue. Often associated with cold intolerance, weight gain, dry skin, and constipation. May be subtle and underdiagnosed, especially in women.    • Diabetes Mellitus: Both hyperglycemia and hypoglycemia can cause fatigue. Look for polyuria, polydipsia, weight loss, or blurry vision in undiagnosed diabetes.    • Adrenal Insufficiency: Think of this when fatigue is paired with hypotension, weight loss, salt craving, or hyperpigmentation. Can be primary (Addison's) or secondary (e.g., due to long-term steroid use).Michael: Hematologic Causes    • Anemia (especially iron deficiency): Very common, especially in menstruating women. Look for fatigue with pallor, shortness of breath on exertion, and sometimes pica (craving non-food items).     • Vitamin B12 or Folate Deficiency: B12 deficiency may present with fatigue plus neurologic symptoms like numbness, tingling, or gait issues. Folate deficiency tends to present with megaloblastic anemia and fatigue.    • Anemia of Chronic Disease: Seen in patients with chronic inflammatory conditions like RA, infections, or CKD. Typically mild, normocytic, and improves when the underlying disease is treated.Michael: Psychiatric Causes    • Depression: A major driver of fatigue, often underreported. May include anhedonia, sleep disturbance, appetite changes, or guilt. Sometimes presents with only somatic complaints.    • Anxiety Disorders: Mental fatigue, poor sleep quality, and hypervigilance can leave patients feeling constantly drained.    • Burnout Syndrome: Especially common in caregivers, healthcare workers, and educators. Emotional exhaustion, depersonalization, and reduced personal accomplishment are key features.Jordan: Infectious Causes    • Epstein-Barr Virus (EBV):Mononucleosis is a well-known cause of fatigue, sometimes lasting weeks. May also have sore throat, lymphadenopathy, and splenomegaly.    • HIV:Consider it in high-risk individuals. Fatigue can be an early sign, along with weight loss, recurrent infections, or night sweats.    • Hepatitis (B or C):Can present with chronic fatigue, especially if liver enzymes are elevated. Screen at-risk individuals.    • Post-viral Syndromes / Long COVID:Fatigue that lingers for weeks or months after viral infection. Often, it includes brain fog, muscle aches, and post-exertional malaise.Important: Chronic Lyme disease is a controversial term without a consistent clinical definition and is often used to describe patients with persistent, nonspecific symptoms not supported by objective evidence of Lyme infection. Leading medical organizations reject the term and instead recognize "post-treatment Lyme disease syndrome" (PTLDS) for persistent symptoms following confirmed, treated Lyme disease, emphasizing that prolonged antibiotic therapy is not effective. Research shows no benefit—and potential harm—from extended antibiotic use, and patients with unexplained chronic symptoms should be thoroughly evaluated for other possible diagnoses.Michael: Cardiopulmonary Causes    •   Congestive Heart Failure (CHF): Fatigue from poor perfusion and low cardiac output. Often comes with dyspnea on exertion, edema, and orthopnea.    •   Chronic Obstructive Pulmonary Disease (COPD): Look for a smoking history, chronic cough, and fatigue from hypoxia or the work of breathing.    •   Obstructive Sleep Apnea (OSA): Daytime fatigue despite adequate hours of sleep. Patients may snore, gasp, or report morning headaches. High suspicion in obese or hypertensive patients.Jordan:Autoimmune / Inflammatory Causes    •   Systemic Lupus Erythematosus (SLE): Fatigue is often an early symptom. May also see rash, arthritis, photosensitivity, or renal involvement.    •   Rheumatoid Arthritis (RA): Fatigue from systemic inflammation. Morning stiffness, joint pain, and elevated inflammatory markers point to RA.    •   Fibromyalgia: A chronic pain syndrome with widespread tenderness, fatigue, nonrestorative sleep, and sometimes cognitive complaints ("fibro fog").Cancer / Malignancy    •   Leukemia, lymphoma, or solid tumors: Fatigue can be the first symptom, often accompanied by weight loss, night sweats, or unexplained fevers. Consider when no other cause is evident.Michael:Medications:Common culprits include:    ◦   Beta-blockers: Can slow heart rate too much.    ◦   Antihistamines: Sedating H1 blockers like diphenhydramine.    ◦   Sedatives or sleep aids: Can cause grogginess and daytime sedation.    •   Substance Withdrawal: Fatigue can be seen in withdrawal from alcohol, opioids, or stimulants. Caffeine withdrawal, though mild, can also contribute.Dr. Arreaza:Whenever we evaluate fatigue, we need to keep an eye out for red flags. These should raise suspicion for something more serious:    •   Unintentional weight loss    •   Night sweats    •   Persistent fever    •   Neurologic symptoms    •   Lymphadenopathy    •   Jaundice    •   Palpitations or chest painThis patient doesn't have these—but that doesn't mean we stop here.Dr. Arreaza:Those are a lot of causes, we can evaluate fatigue following 7 steps:Characterize the fatigue.Look for organic illness.Evaluate medications and substances.Perform psychiatric screening.Ask questions about quantity and quality of sleep.Physical examination.Undertake investigations.So, students, do we send the whole lab panel?Michael:Not necessarily. Labs should be guided by history and physical. But here's a good initial panel:    •   CBC: To check for anemia or infection    • TSH: Screen for hypothyroidism    • CMP: Look at electrolytes, kidney, and liver function    • Ferritin and iron studies    • B12, folate    • ESR/CRP for inflammation (not specific)    • HbA1c if diabetes is on the radarJordan:And if needed, consider:    • HIV, EBV, hepatitis panel    • ANA, RF    • Cortisol or ACTH stimulation testImaging? Now that's rare—unless there are specific signs. Like chest X-ray for possible cancer or TB, or sleep study if you suspect OSA.Dr. Arreaza:Unaddressed fatigue isn't just inconvenient. It can impact on quality of life, affect job performance, lead to mood disorders, delay diagnosis of serious illness, increase risk of accidents—especially driving. So, don't ignore your patients with fatigue!Jordan:And some people—like women, caregivers, or shift workers—are especially at risk.Michael:The cornerstone of treatment is addressing the underlying cause.Jordan:If it's iron-deficiency anemia—treat it. If it's depression—get mental health involved. But there's also: Lifestyle Support: Better sleep hygiene, light physical activity, mindfulness or CBT for stress, balanced nutrition—especially iron and protein, limit caffeine and alcoholDr. Arreaza:Sometimes medications help—but rarely. And for chronic fatigue syndrome, the current best strategies are graded exercise therapy and CBT, along with managing specific symptoms. Beta-alanine has potential to modestly improve muscular endurance and reduce fatigue in older adults, but more high-quality research is needed.SSRI: fluoxetine and sertraline. Iron supplements: Even without anemia, but low ferritin [Anecdote about low ferritin patient]Jordan:This case reminds us to take fatigue seriously. In her case, it may be multifactorial—work stress, caregiving burden, and possibly iron-deficiency anemia. So, how would we wrap up this conversation, Michael?Michael:We don't need to order everything under the sun. A focused history and exam, targeted labs, and being alert to red flags can guide us.Jordan:And don't forget the basics—sleep, stress, and nutrition. These are just as powerful as any prescription.Dr. Arreaza:We hope today's episode on fatigue has given you a clear framework and some practical tips. If you enjoyed this episode, share it and subscribe for more evidence-based medicine!Jordan:Take care—and get some rest~___________________________Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:DynaMed. (2023). Fatigue in adults. EBSCO Information Services. https://www.dynamed.com (Access requires subscription)Jason, L. A., Sunnquist, M., Brown, A., Newton, J. L., Strand, E. B., & Vernon, S. D. (2015). Chronic fatigue syndrome versus systemic exertion intolerance disease. Fatigue: Biomedicine, Health & Behavior, 3(3), 127–141. https://doi.org/10.1080/21641846.2015.1051291Kroenke, K., & Mangelsdorff, A. D. (1989). Common symptoms in ambulatory care: Incidence, evaluation, therapy, and outcome. The American Journal of Medicine, 86(3), 262–266. https://doi.org/10.1016/0002-9343(89)90293-3National Institute for Health and Care Excellence. (2021). Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: Diagnosis and management (NICE Guideline No. NG206). https://www.nice.org.uk/guidance/ng206UpToDate. (n.d.). Approach to the adult patient with fatigue. Wolters Kluwer. https://www.uptodate.com (Access requires subscription)Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

In the second part of a two-episode series on chronic kidney disease (CKD), Dr Hannah Rosa is joined again by Dr Will Hinchliffe, a Consultant in Renal and General Medicine working in the North East and North Cumbria. They discuss the management options for CKD that can be initiated in primary care. They first look at how to empower patients with lifestyle and dietary advice, then the medical treatment options we have for CKD and when to start them, before finishing with holistic care, especially with regards to cardiovascular disease. This episode is mainly based on the NICE assessment and management guideline for CKD, but it also draws on other recent guidelines from Kidney Disease Improving Global Outcomes (KDIGO) and the International Society of Nephrology as it aims to help you to improve the lives of your patients with CKD.Access episode show notes containing key references and take-home points at:https://gpnotebook.com/en-GB/podcasts/renal-medicine/ep-165-chronic-kidney-disease-among-adults-in-primary-care-testing-diagnosis-and-referral.Did you know? With GPnotebook Pro, you can earn CPD credits by tracking the podcast episodes you listen to. Learn more.

Join us for an inspiring episode of the Diary of a Kidney Warrior Podcast as we sit down with Ravi—a fellow Kidney Warrior whose story is one of courage, connection, and unshakeable will. From his unexpected diagnosis of Chronic Kidney Disease (CKD) to life on dialysis, Ravi opens up about the challenges and triumphs that have shaped his journey.   What began as a routine post-holiday health concern quickly became a life-altering revelation. Ravi walks us through the early warning signs, the shock of diagnosis, and the complexities of seeking care amid a global pandemic. As dialysis buddies turned friends, Ravi and our host share a powerful camaraderie that highlights the strength found in community.   In this candid conversation, Ravi speaks openly about the physical, mental, and emotional toll of CKD—detailing side effects, collapsing from poor health, and the resilience needed to push through. Balancing a demanding career in IT, he reveals how he copes with the daily realities of dialysis and the hope of an eventual transplant.   Whether you're newly diagnosed or supporting someone with CKD, Ravi's insights offer encouragement, practical advice, and heartfelt wisdom. He champions the importance of early detection, mental well-being, and finding purpose amidst the struggle.  

Welcome to HCPLive's 5 Stories in Under 5—your quick, must-know recap of the top 5 healthcare stories from the past week, all in under 5 minutes. Stay informed, stay ahead, and let's dive into the latest updates impacting clinicians and healthcare providers like you! Interested in a more traditional, text rundown? Check out the HCPFive! Top 5 Healthcare Headlines for June 30-July 6, 2025: Sebetralstat FDA-Approved as First Oral, On-Demand for Hereditary Angioedema The FDA approved sebetralstat (Ekterly) on July 7, 2025, as the first oral, on-demand treatment for hereditary angioedema attacks in patients aged 12 and older, backed by phase 3 KONFIDENT trial data. Rilparencel Improves eGFR Slope in Phase 2 CKD, Diabetes REGEN-007 Trial Rilparencel significantly slowed kidney function decline in CKD patients with diabetes in the REGEN-007 trial, showing dose-responsive eGFR slope improvements after two injections per kidney. J&J Submits sNDA to FDA for Lumateperone (CAPLYTA) to Prevent Schizophrenia Relapse J&J filed a supplemental NDA for lumateperone after phase 3 data showed a 63% reduction in schizophrenia relapse risk compared to placebo. FDA Publishes CRLs for Past Drug, Biological Product Applications The FDA publicly released over 200 Complete Response Letters from 2020–2024 to increase regulatory transparency and help accelerate future drug approvals. FDA Grants TSND-201 Breakthrough Therapy Designation for PTSD TSND-201 (methylone) received Breakthrough Therapy designation for PTSD on July 10, 2025, offering a potential rapid-acting alternative to SSRIs, which can take up to 12 weeks for full effect.

Amino acids are a fundamental building block for fur, muscle, and every other living tissue on Earth. These molecules come in “left-handed” (L) and “right-handed” (D) forms, a bit like gloves that fit different hands or mirror images. Life largely runs on the left-handed set, so biologists once assumed the right-handed versions were irrelevant. Yet nature quietly manufactures these D-amino acids and they can play a role in certain biological processes. In research led by Japanese analytical chemist Ren Kimura of the R&D-Analytical Science Research department of the Kao Corporation, Japan, researchers reveal that these overlooked molecules may offer an early-warning beacon for one of the most common and deadly ailments in cats, chronic kidney disease (or CKD for short), and they may even have potential in diagnosing human conditions.

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/the-latest-data-in-ckd-progression-10197SummaryEmerging evidence highlights the potential of GLP-1 receptor agonists (GLP-1 RAs) to slow CKD progression and reduce cardiovascular and kidney-related mortality in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). Yet, despite updated guidelines, these therapies remain underused. This program will explore the latest clinical data supporting the role of GLP-1 RAs in risk mitigation and provide practical strategies for implementing guideline-based treatment to reduce cardio-renal risk and improve outcomes in patients with T2D and CKD.This podcast was recorded and is being used with permission of the presenters.Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Discuss emerging data on GLP-1 RA therapy for CKD progression in T2DImplement guideline-based care to minimize CV risk and CKD progressionThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an educational grant from Novo Nordisk.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Chronic kidney disease, or CKD, is the most common cause of death in senior…

Chronic kidney disease, or CKD, is the most common cause of death in senior cats. Unfortunately, it's usually not diagnosed until symptoms are advanced. But when it's caught early, targeted...

In the first of a two-episode series on chronic kidney disease (CKD), Dr Hannah Rosa is joined by Dr Will Hinchliffe, a Consultant in Renal and General Medicine working in the North East and North Cumbria. They discuss which people are at risk of CKD, how to test for it and diagnose it and, lastly, which patients require a referral to secondary care. This episode is mostly based on the NICE guideline on assessment and management of CKD and aims to help you to improve the lives of your patients by diagnosing CKD earlier and referring those who may benefit from specialist input sooner.Access episode show notes containing key references and take-home points at:https://gpnotebook.com/en-GB/podcasts/renal-medicine/ep-163-chronic-kidney-disease-among-adults-in-primary-care-testing-diagnosis-and-referral.Did you know? With GPnotebook Pro, you can earn CPD credits by tracking the podcast episodes you listen to. Learn more.

Dee went to A&E with persistent headaches and was diagnosed with CKD. She held off dialysis with the aid of a health coach, diet and exercise. But still eventually had to start. Creating her podcast ‘Diary of a Kidney Warrior Podcast' has helped her reach patients all over the world. Listen to her journey here….. Disclaimer: All views, information or opinions expressed in this podcast series are solely my own.The primary purpose of this podcast series is to inform, but it does not constitute medical or other professional advice or services. Please seek advice from your own medical teams regarding your own health.

From Diagnosis to Artivism: Steve's Extraordinary Kidney Warrior Journey   In this powerful episode of Diary of a Kidney Warrior Podcast, Dee sits down with Steve — a passionate creative whose life was forever changed by an unexpected diagnosis of chronic kidney disease (CKD).   At just 30% kidney function and no warning signs, Steve's diagnosis came as a shock. He takes us through the moment his world shifted: a sudden phone call that catapulted him into the reality of dialysis. What follows is a deeply human story of resilience — navigating peritoneal dialysis, transitioning to haemodialysis, and balancing the demands of treatment with the challenges of self-employment in web design.   But this is no ordinary journey.   Steve opens up about receiving his first kidney transplant, the hope it brought, and the heartbreak when things took a turn — sending him back to dialysis and confronting the fragility of life with CKD. Throughout it all, he emphasises the critical importance of self-advocacy in the healthcare system, offering insights that every patient or caregiver needs to hear.   What truly sets Steve apart is how he channels pain into purpose. Through painting, he found not just therapy, but a voice — using art as activism to raise awareness about kidney disease. His work, featured in exhibitions supporting Kidney Care UK, is raw, reflective, and at times, joyfully humorous — a visual diary of his fight and spirit.   The episode builds to a beautiful full-circle moment as Steve shares the emotional story of receiving a second transplant — this time from his brother — and the freedom that followed. His message is clear: creativity can be healing, storytelling is powerful, and no one walking this journey is alone.   If you're living with CKD, supporting a loved one, or simply need a reminder of the strength of the human spirit, this episode will leave you inspired, informed, and deeply moved.   Follow Diary of a Kidney Warrior:  

In this episode of the Yumlish podcast, Shireen Abdullah speaks with Dr. Anshu Chaturvedi—a renal clinical dietitian with over 12 years of experience—and discusses how personalized nutrition can transform chronic disease management. Sharing both professional insights and personal experience with IBS, she explains how intermittent fasting and thoughtful meal sequencing can improve metabolic health and reduce blood sugar levels. Dr. Chaturvedi emphasizes that food is not “good” or “bad,” but should be tailored to individual needs. She provides practical strategies for portion control, timing and plant-based eating while also revealing her own daily routine for managing wellness. This episode is full of accessible, culturally inclusive guidance for anyone looking to eat smarter and live healthier.Dr. Anshu Chaturvedi is a highly experienced Renal Clinical Dietitian with a Ph.D. in Renal nutrition, over 12 years of expertise in clinical nutrition, specializing in the management of various lifestyle disorders including diabetes mellitus, chronic kidney disease (CKD) and related conditions. She focuses on the development of personalized nutritional interventions that enhance the health outcomes of patients “Every food is good—until and unless your body is accepting that food. It's not about good or bad food. It's about what works for you and how you care for your health with intention.” Question of the Day:Have you made any changes to your diet recently? What do those changes look like?On This Episode You Will Learn:How intermittent fasting can be tailored to different body types and health needs.The importance of meal sequence (fiber → protein → carbs) for better blood sugar control.Why inflammation and poor metabolic health are core contributors to diabetes.How plant-based diets can reduce inflammation and support diabetes management.Practical tips for portion control and timing your meals for long-term health benefits.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Connect with Dr. Chaturvedi!Instagram URL: https://www.instagram.com/anshu_chaturvedii?igsh=MW00eG5rMmVxazBmMA==Facebook URL: https://www.facebook.com/share/18s6KR9T9t/LinkedIn URL: https://www.linkedin.com/in/anshu-chaturvedi-1027a796?utm_source=share&utm_campaign=share_via&utm_content=profile&utm_medium=android_app

In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of angiotensin receptor blockers (ARBs).  Key Concepts ARBs are equally efficacious as ACE inhibitors when used for hypertension, heart failure with reduced ejection fraction (HFrEF), chronic kidney disease (CKD) with proteinuria, and post-MI care. Some limited evidence suggests that they might be better in reducing albuminuria in patients with diabetes. ARBs are generally better tolerated than ACEi due to a lower risk of angioedema and dry cough.  While most ARBs are comparable to each other, small differences exists regarding hepatic metabolism (CYP metabolism for losartan, telmisartan, and azilsartan), degree of blood pressure lowering (generally better with azilsartan, olmesartan, valsartan, and candesartan), and additional pharmacological effects (telmisartan with PPAR-Y agonism, losartan with uricosuric effect). ARBs are contraindicated in pregnancy, those with bilateral renal artery stenosis, and those with previous angioedema to ARBs. The most common adverse effects include hypotension and hyperkalemia, but in rare cases acute renal impairment can also occur. Baseline serum creatinine and potassium should be monitored in patients taking ARBs. After initiation or dose adjustment, blood pressure, serum creatinine, and potassium should be repeated in 1-2 weeks. Signs and symptoms of hypotension as well as angioedema should be monitored throughout the treatment period.

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Dr. Reaves and Dr. Sarnak on "Benefits and risks of intensive blood pressure control in CKD patients: what does the current evidence tell us?" from nephSAP Vol 24, No 2.

Alice Sheridan, MD, FASN, and Martina McGrath, MD, FASN, speak with guest editors Dr. Reaves and Dr. Sarnak on "Benefits and risks of intensive blood pressure control in CKD patients: what does the current evidence tell us?" from nephSAP Vol 24, No 2.

In this powerful and deeply personal episode of Diary of a Kidney Warrior Podcast, we meet Christy—an extraordinary kidney warrior whose story of resilience will inspire anyone facing life's toughest battles.   Christy takes us back to 2006, when a life-threatening crisis landed her in a coma, leading to kidney failure caused by septicaemia and peritonitis. What followed was nearly two decades of living with chronic kidney disease (CKD)—a journey marked by dialysis as a young adult, the heartbreak of a failed transplant, and the constant balancing act of managing additional health complications.   But Christy's story doesn't stop at survival. She shares how she transformed her adversity into advocacy, building a vibrant online community and launching her own podcast, Chronically Christy, to connect with and uplift other kidney patients.   With honesty and wisdom, Christy speaks about:

Listener feedback on cardiac sarcoidosis, SA node ablation, surgical AF ablation, chronic kidney disease protection, and recruiting for clinical trials are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I Listener Feedback EHJ paper Mathijssen et al https://doi.org/10.1093/eurheartj/ehaf338 Nordenswan et al https://www.ahajournals.org/doi/full/10.1161/CIRCEP.117.006145#tab-contributors II IST HR Case Reports https://doi.org/10.1016/j.hrcr.2025.05.017 Lakkireddy et al https://doi.org/10.1016/j.hrthm.2021.07.010 III Survival After Surgical AF ablation during CABG McClure et al https://doi.org/10.1093/europace/eux336 Schaffer et al https://doi.org/10.1016/j.athoracsur.2025.03.044 IV Finerenone with Empagliflozin in CKD and DM The Confidence Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2410659 V Recruiting for Important Trials and the Stature of EP as a Profession Two UK Cardiology Trials Struggle to Recruit Patients https://www.medscape.com/viewarticle/two-uk-cardiology-trials-struggle-recruit-patients-2025a1000ffs CRAFT HF https://clinicaltrials.gov/study/NCT06505798 BRITISH https://doi.org/10.1016/j.ahj.2023.09.008 PROFID https://profid-project.eu/profid-ehra-trial/ You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net

CME credits: 0.25 Valid until: 06-06-2026 Claim your CME credit at https://reachmd.com/programs/cme/nonsteroidal-mra-sglt2i-in-people-with-ckd-t2d-current-evidence-and-rationale-for-combination-therapy/29909/ Can combining a nonsteroidal MRA and an SGLT2 inhibitor unlock new clinical potential for patients with type 2 diabetes and chronic kidney disease (CKD)? In this expert discussion, Dr. Jennifer Green and Dr. Hiddo Heerspink review the latest findings from the CONFIDENCE trial, which demonstrated a significant additive reduction in albuminuria—an important surrogate marker for kidney and cardiovascular risk—when finerenone and empagliflozin are used together. They explore the clinical rationale behind combination therapy, address persistent challenges in CKD detection, and consider the practical implications for implementing these therapies in high-risk populations.=

Why You Should Listen:  In this episode, you will learn about chronic kidney disease and how to address the Kidneydemic with Renology. About My Guest: My guest for this episode is Dr. Robin Rose.  Robin Rose, MD began a journey into holistic healing in her teens in the mid-sixties beginning with nutrition and botanical medicine and yoga and meditation.  Over the years her journey included time living in India and working with both village doctors and healers.  She became a health food chef and inspired many to change their habits.  Before long she was enrolled in an RN program and then a family nurse practitioner program.  Aware that the education wasn't complete, she attended University of Arizona College of Medicine; while also serving as a medical student board member for the American Holistic Medical Association.  During residency, she continued learning Chinese medicine, acupuncture, osteopathy, energy medicine, and herbal medicine.  Her main practice was in Ashland, Oregon where she served a community eager to integrate many healing modalities into the conventional setting, including innovative care in the hospital.  In the past decade after her own alarming health challenges with kidney cancer and advanced kidney disease, she became agile in regenerative medical approaches to kidney care.  She created a new specialty called Renology; a new concept of "Kidney Success" not Kidney Failure.  When she discovered peptides and especially bioregulator peptides, she led the brigade to new heights of seeing success in a field that had not embraced this kind of care.  Her recent book "Renology Peptides" is a nearly 800 page text on how to achieve this renewal of health.  Her current intention is to raise awareness of the role of kidney in wellbeing and how we can all celebrate this success.  Key Takeaways: What is the purpose of the kidneys? What symptoms are observed in chronic kidney disease? Is kidney disease a catabolic process? Is kidney disease genetic or epigenetic? What are the stages of kidney disease? What are the best tests and lab markers? What might elevations or phosphorous or potassium suggest? What is the kidney-gut axis? What is the role of endothelial health in kidney disease? What role do the mitochondria play?  How do infections and environmental toxicants contribute to kidney disease? What is the role of oxalates in kidney health? How might carbon dioxide guide treatment? Does cellular senescence play a role? What is the connection between the kidneys and the teeth? How do the limbic system and mental/emotional health impact the kidneys? What treatment intervention warrant exploration? Where do dialysis and transplantation come into the discussion? What role might peptides and peptide bioregulators play? Connect With My Guest:  RenologyIsKidneySuccess.com Interview Date: May 21, 2025 Transcript: To review a transcript of this show, visit https://BetterHealthGuy.com/Episode217. Additional Information: To learn more, visit https://BetterHealthGuy.com. Follow Me on Social Media: Facebook - https://facebook.com/betterhealthguy Instagram - https://instagram.com/betterhealthguy X - https://twitter.com/betterhealthguy TikTok - https://tiktok.com/@betterhealthguy Disclaimer:  The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority. 

Why You Should Listen:  In this episode, you will learn about chronic kidney disease and how to address the Kidneydemic with Renology. About My Guest: My guest for this episode is Dr. Robin Rose.  Robin Rose, MD began a journey into holistic healing in her teens in the mid-sixties beginning with nutrition and botanical medicine and yoga and meditation.  Over the years her journey included time living in India and working with both village doctors and healers.  She became a health food chef and inspired many to change their habits.  Before long she was enrolled in an RN program and then a family nurse practitioner program.  Aware that the education wasn't complete, she attended University of Arizona College of Medicine; while also serving as a medical student board member for the American Holistic Medical Association.  During residency, she continued learning Chinese medicine, acupuncture, osteopathy, energy medicine, and herbal medicine.  Her main practice was in Ashland, Oregon where she served a community eager to integrate many healing modalities into the conventional setting, including innovative care in the hospital.  In the past decade after her own alarming health challenges with kidney cancer and advanced kidney disease, she became agile in regenerative medical approaches to kidney care.  She created a new specialty called Renology; a new concept of "Kidney Success" not Kidney Failure.  When she discovered peptides and especially bioregulator peptides, she led the brigade to new heights of seeing success in a field that had not embraced this kind of care.  Her recent book "Renology Peptides" is a nearly 800 page text on how to achieve this renewal of health.  Her current intention is to raise awareness of the role of kidney in wellbeing and how we can all celebrate this success.  Key Takeaways: What is the purpose of the kidneys? What symptoms are observed in chronic kidney disease? Is kidney disease a catabolic process? Is kidney disease genetic or epigenetic? What are the stages of kidney disease? What are the best tests and lab markers? What might elevations or phosphorous or potassium suggest? What is the kidney-gut axis? What is the role of endothelial health in kidney disease? What role do the mitochondria play?  How do infections and environmental toxicants contribute to kidney disease? What is the role of oxalates in kidney health? How might carbon dioxide guide treatment? Does cellular senescence play a role? What is the connection between the kidneys and the teeth? How do the limbic system and mental/emotional health impact the kidneys? What treatment intervention warrant exploration? Where do dialysis and transplantation come into the discussion? What role might peptides and peptide bioregulators play? Connect With My Guest:  RenologyIsKidneySuccess.com Interview Date: May 21, 2025 Transcript: To review a transcript of this show, visit https://BetterHealthGuy.com/Episode218. Additional Information: To learn more, visit https://BetterHealthGuy.com. Follow Me on Social Media: Facebook - https://facebook.com/betterhealthguy Instagram - https://instagram.com/betterhealthguy X - https://twitter.com/betterhealthguy TikTok - https://tiktok.com/@betterhealthguy Disclaimer:  The content of this show is for informational purposes only and is not intended to diagnose, treat, or cure any illness or medical condition. Nothing in today's discussion is meant to serve as medical advice or as information to facilitate self-treatment. As always, please discuss any potential health-related decisions with your own personal medical authority. 

Struggling to balance work and kidney disease? You're not alone — and this episode is your essential guide to thriving professionally and medically. We're joined by Dr. Jacquie, a leading expert in occupational health, to explore the critical intersection of employment, rights, and wellbeing for people living with chronic kidney disease (CKD).  

New Steroid Rules for Lupus - Dr. Michelle Petri Management of CKD in Lupus Nephritis - Dr. HJ Anders HCQ Levels and Adherence - Dr. Nathalie Costedoat-Chalumeau Lupus Nephritis Guidelines - a debate - Drs. Michelle Petri and Maria Dall'Era Nephrologists Approach to Lupus Nephritis - Dr. Brad Rovin Voclosporin and Steroids in Lupus Nephritis - Dr. Jack Cush

Targeting the cardiovascular (CV)-kidney-metabolic (CKM) axis may improve outcomes in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) by addressing interconnected metabolic, kidney, and CV risks.   Credit available for this activity expires: 5/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002559?ecd=bdc_podcast_libsyn_mscpedu

Health care executive and patient advocate Aja Best discusses her article, "How early CKD diagnosis can save lives: a transplant survivor's journey." She shares her harrowing personal experience with a delayed diagnosis of IgA nephropathy during pregnancy, which led to a challenging path through dialysis and ultimately to a life-saving kidney transplant. Aja highlights the often-silent progression of chronic kidney disease (CKD), a growing global health crisis, and points to critical gaps in the health care system that prevent timely intervention. The conversation explores the importance of early screening, proactive and coordinated care, the potential of technology and predictive analytics to improve patient outcomes, and the power of patient advocacy. Aja passionately calls for systemic changes and greater awareness to ensure others don't face the same missed opportunities she did. The key takeaway is: Early CKD detection through routine screening and a more integrated, patient-centered health care approach can significantly alter disease progression, improve lives, and reduce the burden of this widespread condition. Our presenting sponsor is Microsoft Dragon Copilot. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Now you can streamline and customize documentation, surface information right at the point of care, and automate tasks with just a click. Part of Microsoft Cloud for Healthcare, Dragon Copilot offers an extensible AI workspace and a single, integrated platform to help unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise—and it's built on a foundation of trust. It's time to ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Modern medicine has made significant strides in managing chronic diseases, yet many elderly patients with multiple conditions continue to deteriorate under standard care. Conventional therapies often overlook the root causes of chronic degeneration, such as oxidative stress, mitochondrial dysfunction, toxin accumulation, and nutritional deficiencies. IntegrativeOrthomolecular Medicine (IOM) offers a solution-oriented framework that emphasizes restoring biochemical balance through therapeutic nutrition, detoxification, metabolic support, and lifestyle interventions. This case study illustrates the practical application and impressive results of an IOM protocol in an elderly woman with T2DM, CKD with renal insufficiency, Parkinsonism, and recurrent infections.In this episode George discusses the case study of a 94 year old woman who made significant improvements using Orthromolecular nutrition. www.georgebatista.com

We are giving you a fresh take on celebrity health news and medical news that you can't get anywhere else! We're talking about Al B. Sure!'s wild survival story (coma, liver transplant, and those Diddy rumors), plus Nate Robinson's journey from NBA All-Star to kidney transplant survivor.I misspoke on the LIVE today. I said that it is standard of care for one to be referred to a nephrologist when the eGFR is less than 30. I meant to say that it is standard of care to refer a patient to a nephrologist when the eGFR is less than 60 and when the patient is in stage 3 CKD.This podcast is intended to be informational only.  It is not a medical consultation, nor is it personalized medical advice.  For medical advice, please consult your physician.Did you hear about Fox News commentator Camryn Kinsey fainting on live TV? Let's talk about why fainting happens—and why it's not just about “catching your breath.” Also, have you heard about That's So Raven, Disney Star, Rondell Sheridan's pancreatitis battle? It's a wake-up call for sure, and we'll talk about what you need to know plus so much more!#HealthHappyLifePodcast #DrFrita #MedicalMondays #MedicineInTheNewsHere are a few helpful resources to help on your journey to wellness:▶️ Subscribe so you will never miss a YouTube video.

The authors evaluate the efficacy and safety of emerging therapeutic strategies for CKD management, including sodium-glucose cotransporter 2 inhibitors (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), finerenone, sacubitril/valsartan, and potassium binders. Read the full text manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70014.

In this podcast, Dr. Valentin Fuster reviews findings from the SUMMIT trial, which examined how tirzepatide impacts patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD). The study revealed that while tirzepatide improved cardiovascular outcomes and slightly boosted kidney function, the benefits in CKD patients may stem from mechanisms beyond glomerular filtration alone.

During this episode a panel of experts discuss the patient journey through the interpretation and application of safety and efficacy data to establish and maintain protocols designed to address optimal VTE treatment pathways. Claim CE and MOC Credit at bit.ly/VTEPJ6 

In this episode, Lori talks with nephrologist Dr. Arun Malhotra about what inspired him to pursue nephrology and dives into an important discussion about the connection between chronic kidney disease (CKD) and high potassium, also known as hyperkalemia. They cover symptoms to watch for, the role of diet, how to manage potassium levels, and the importance of working closely with healthcare providers.

The interplay between cardiovascular disease, chronic kidney disease (CKD), and diabetes is complex and often underappreciated.   Credit available for this activity expires: 4/30/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002395?ecd=bdc_podcast_libsyn_mscpedu

In this episode, we explore how data analytics and clinical expertise can transform kidney health management for health plans. Joining the conversation is Joe Vattamattam, Founder and President of Healthmap Solutions, who shares insights on why tackling chronic kidney disease (CKD) and end-stage renal disease (ESRD) is crucial. Tune in to learn how Healthmap leverages technology, clinical support, and innovative strategies to improve outcomes for patients and providers.This episode is sponsored by Healthmap Solutions.

In this powerful episode of Diary of a Kidney Warrior Podcast, host Dee Moore is joined by Nick Palmer, who shares his extraordinary journey of living with chronic kidney disease (CKD) and focal segmental glomerulosclerosis (FSGS). Diagnosed at just 19 years old, Nick opens up about navigating the complex realities of kidney disease as a young adult—balancing university, a demanding career, and the emotional toll of a condition that would require multiple transplants and ongoing dialysis.   With unflinching honesty, Nick reflects on his decision to decline a third kidney transplant and instead embrace home nocturnal dialysis—a choice that profoundly improved his quality of life, restored his sense of independence, and helped him reclaim control of his health. He discusses the impact of this decision on his mental well-being, family life, and career, and how it ultimately allowed him to thrive in ways he never expected.   Nick's story challenges traditional narratives around kidney treatment, shining a light on the importance of patient choice, education, and mental health advocacy in chronic illness care. This episode is a must-listen for anyone navigating kidney disease, healthcare professionals, or anyone seeking inspiration from a story of resilience and informed self-advocacy.   Key topics include: Living with FSGS and the impact of early diagnosis The emotional and physical toll of dialysis in early adulthood The recurrence of FSGS post-transplant Choosing nocturnal dialysis and the profound benefits for quality of life Mental health, self-advocacy, and redefining what it means to live fully with CKD   Follow Diary of a Kidney Warrior:  

From 2013 .... Lori Hartwell discusses her book "Chronically Happy: Joyful Living in Spite of Chronic Living." Hartwell has lived for most of her life with chronic kidney disease. She is the founder and president of the Renal Support Network .... and co-host of "KidneyTalk," a biweekly webcast centered on issues related to CKD.

Let's talk real about kidney-friendly diets—without the fear-mongering. In this episode, Dr. Marianne welcomes Vanessa Connelly, RD (@grainandgreen.kidneys), for a candid conversation about what it actually means to eat in a kidney-supportive way—without triggering disordered eating patterns. Vanessa shares how she helps folks navigate complex medical nutrition guidance with compassion, nuance, and zero shame. Whether you're living with chronic kidney disease, supporting a loved one, or just curious about how diet culture shows up in medical spaces, this episode is a must-listen. ABOUT VANESSA CONNELLY, RD Vanessa is a registered dietitian nutritionist and board certified kidney nutrition specialist with over 20 years experience working with folks who have chronic kidney disease. She is a South Carolina living Maryland native who has helped hundreds of clients with CKD slow down or prevent dialysis without giving up their favorite foods. Her passion is to help people understand how eating the right foods can truly help preserve and protect kidney function. She's about ditching the stress and helping you thrive with CKD one bite at a time. Vanessa graduated from the University of Maryland at College Park and attended the Medical University of South Carolina to complete the requirements of the Dietetic Internship. When not working you can find Vanessa busy living life with her husband and two kiddos, listening to true crime podcasts or enjoying a workout. CONTACT VANESSA IG: @grainandgreen.kidneys TikTok: @grainandgreen.kidneys Website: www.grainsandgreenkidneys.com Email: vanessa@grainsandgreenkidneys.com CHECK OUT MORE EPISODES ON HEALTH & NUTRITION:   > Diabetes, Accessibility, and Eating Disorders on Apple or Spotify. > Ableism & Common Myths About Diabetes on Apple or Spotify.   INTERESTED IN HANGING OUT MORE IN DR. MARIANNE-LAND? Follow me on Instagram @drmariannemiller Join my $99/month Dr. Marianne-Land's Binge Eating Recovery Membership Program Live in the UK, US, or Canada? Sign up for 1:1 binge eating recovery coaching via my Elite Binge Eating Recovery Method  Live in California, Texas, or Washington, D.C. and interested in eating disorder therapy with me? Sign up for a free, individual 15-minute phone consultation via my website, and I'll get you to where you need to be! Check out my blog. Want more information? Email me at hello@mariannemiller.com

In this episode, a panel of experts discuss existing and emerging VTE (venous thromboembolism) treatment options for the complex patient, such as a patient who has been diagnosed with cancer, end stage renal disease (ESRD), chronic kidney disease (CKD), or is obese.  Claim CE and MOC Credit at https://bit.ly/VTEHBCPX

In this deeply moving episode of Diary of a Kidney Warrior Podcast, host Dee sits down with the incredible Rachel, a true example of strength and resilience in the face of Chronic Kidney Disease (CKD). Diagnosed as a child, Rachel's story spans decades — from routine check-ups in her youth to navigating the complexities of motherhood with CKD, dialysis, and ultimately receiving a life-saving kidney transplant from her mother.   With warmth and honesty, Rachel reflects on the early signs of CKD, the emotional and physical challenges of pregnancy with kidney disease, and the toll dialysis took on her young family. Through it all, her determination to stay strong for her children and her unshakeable hope carried her forward.   This episode is not just about survival — it's about the importance of support, the power of informed choices, and the life-changing gift of organ donation. Rachel's story will leave you inspired and uplifted.   Whether you're a patient, carer, or healthcare professional, this conversation offers vital insights, encouragement, and a powerful message of perseverance and gratitude.   Follow Diary of a Kidney Warrior:  

Did you know that patient registries play a vital role in improving kidney disease treatment and outcomes? In this episode, we're diving into the KidneyCARE Study—a patient registry that uses real-world data to better care for people with kidney disease. We sat down with experts as they explained what a patient registry is and why people with kidney disease may want to join the KidneyCARE Study. In today's episode we heard from:    Kerry K. Willis PhD- Dr Willis is the Chief Scientific Officer of the National Kidney Foundation (NKF). Since joining NKF in 1998, her major focus has been on the analysis and application of clinical evidence to improve care and outcomes for people living with kidney disease. She oversees all NKF-sponsored research and professional education programs, including the Spring Clinical Meetings; population health programs that facilitate health system and practice engagement around CKD as a quality improvement target; the Kidney Disease Outcomes Quality Initiative (KDOQI) clinical practice guidelines; KDOQI quality measurement initiative; and four peer-reviewed journals devoted to chronic kidney disease. She led the development of and currently manages the Kidney CARE (Community Access to Research Equity) Study, the first national CKD patient registry to combine patient-reported data with clinical data from electronic health records.     Rachel Claudin, BS, CCLS- Rachel Claudin is the Patient-Centered Research Director at the National Kidney Foundation (NKF). Her main work for the past three years has been focused on the advancement of the KidneyCARE Study. As a person living with Lupus Nephritis, she is excited for the patient-entered data collected by the Study to increase and improve kidney care research. Previous to the NKF, Rachel worked in hospital and hospice settings advocating for patients utilizing the shared decision-making model of healthcare. Cari Maxwell- Cari has lived with Polycystic Kidney Disease (ADPKD) since 1989, and her personal experience, along with the experiences of her father and two siblings, fuels her advocacy for advancements in PKD treatment. She participated in the Tolvaptan Reprise trial, which led to the first-ever FDA-approved treatment for ADPKD—a treatment she continues to benefit from today. As a member of the NKF Kidney Advocacy Committee, Cari is passionate about promoting patient education, early detection, and scientific progress through patient-centered clinical research. She is dedicated to ensuring that others have access to life-changing treatments and are empowered to advocate for their health through proactive care. Cari currently works in health care cost containment strategies, where she applies her expertise to enhance patient access and outcomes. Sandy Gilbert PhD- Sandy Gilbert is the Senior Director of Patient Outcomes Research at the National Kidney Foundation (NKF), where she manages the KidneyCARE (Community Access to Research Equity)™ Study. Since joining NKF in 2024, her focus has been on developing and overseeing this pioneering national kidney disease patient registry, the first to integrate patient-reported data with clinical data from electronic health records. The goal of the Registry is to generate critical insights into disease progression, treatment outcomes, and health disparities, in support of NKF's mission to improve kidney health and drive innovation in kidney research and healthcare. Sandy works closely with teams of researchers and health system partners to expand the study's reach and ensure that it reflects the needs of diverse patient populations, including those from underserved communities. Additional Resources: KidneyCare Study Information Contact Information: Call: 212.889.2210 ext.134 M-F 10am-4pm CT  Email: kidneycarestudy@kidney.org   Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.

Tune in to The Heart of Innovation this week as we share an incredible story of a young woman who helped save her grandfather's life and now is trying to save others through organ donation advocacy. Since it's National Kidney Month, Emmy Award-winning journalist Kym McNicholas and Dr. John Phillips interview Danica Almazan, RN and Miss Marin County 2025, whose family's courageous fight against kidney disease sparked a powerful mission of hope. You might wonder why we are talking about kidney disease on a show about cardiovascular and vascular health. Kidney disease, especially in advanced stages can lead to peripheral artery disease, which is poor circulation in mainly the legs, and lead to amputation. Many of the peripheral artery disease (PAD) patients both Kym and Dr. John support have CKD and ESRD, some of which are also in need of a kidney transplant. They want to get the word out there on the importance of kidney health as well as raise awareness that all kidney disease patients should be checked for peripheral artery disease and to find a doctor who specializes in opening the small vessels below the knee and into the foot, which is where kidney disease patients are typically stricken with PAD. Whether you're impacted by peripheral artery disease, kidney health challenges, or simply want to understand the power of family support, this episode is a must-watch! #KidneyHealth #OrganDonation #TheHeartOfInnovation #NationalKidneyMonth #MissMarin2025 #peripheralarterydisease #padsupport #CLI #criticallimbischemia

Last year, 9,000 deceased donor kidneys were discarded due to storage and time limitations. A kidney “life support” machine could change that. Also, the SS United States will join Florida's 4,300 artificial reefs—human-made places for fish and other marine life to live. How do these reefs work?The Effort To Save Thousands Of Donor Kidneys From Being WastedSylvia Miles was diagnosed with lupus in 2006, a chronic autoimmune disease that causes the body's immune system to attack healthy tissue—including her kidneys.Miles, who lives in Indianapolis, was later diagnosed with advanced kidney disease, and was in need of a kidney transplant.Kidney diseases are one of the leading causes of death in the United States with 37 million people living with chronic kidney disease. Together with advanced kidney disease—the later stage of CKD—it cost Medicare billions of dollars in recent years.People like Miles, who need a kidney transplant, wait an average of five years—often on dialysis.But despite the long waitlists and organ shortages, around 9,000 kidneys from deceased donors last year were discarded due to perceived issues with their viability. A new Indiana-based organization, 34 Lives, is working to limit that waste and rehabilitate the organs.Read the rest of this article on sciencefriday.com.Ocean Liner SS United States Will Become An Artificial ReefThis week, after a notable career, the SS United States, a 1950s ocean liner, took her sunset cruise. Like many retirees, the ship is heading south—from Philadelphia to Florida—where she'll be reinventing herself. In this next chapter, the SS United States will have new passengers: fish and other marine creatures. The ship will be sunk to the bottom of the sea and turned into an artificial reef, joining more than 4,300 artificial reefs off the coast of Florida.Other sunken ships have become artificial reefs in the past, which have helped boost marine life as well as scuba diving and fishing tourism. Host Flora Lichtman speaks with Scott Jackson, a regional specialized agent with the Florida Sea Grant and University of Florida IFAS extension, about the science behind artificial reefs, and what has been learned from decades of research.Transcripts for each segment will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

In this special collaboration with NephMadness, we're diving into the world of nephrotoxins with an expert panel from Virginia Commonwealth University. NephMadness is an educational competition modeled after March Madness, and this year, one of the featured regions focuses on plant-based nephrotoxins. Together, with our expert panel we break down the competing nephrotoxin teams: Tubular Toxins vs. Oxalate Offenders. Joining us are Dr. Anna Vinnokova (Nephrologist), Dr. Rachel Khan PharmD (Neph pharmacist), Dr. Ethan Downes (Nephrology fellow), and the legendary nephrotoxicologist, Dr. Josh King (Board certified Nephrologist and Toxicologist). We ALMOST named this episode "Getting Downe with the Mad Neph King and the Bean Queens"... but we didn't, your welcome. After the show, go to the blog and vote for your favorite!Expect irreverent musings, deep dives into toxic plant exposures, and a mystery case reveal that will leave you questioning your diet.Topics and Timeline of Episode:IntroListener Guesses With Josh and Ryan– 8:30Listener Winner – 25:42NephMadness and Guest Introductions – 28:07Toxin Reveal – 33:41NEJM Case reportTubular Toxins – 35:46Aristolochic Acid & the Belgian Weight-Loss Clinic Outbreak – 40:30Black Licorice & Its Surprising Toxic Effects – 47:16The Oxalate Offenders Team: How Dietary Oxalates Harm the Kidneys – 52:00Historical Context: First recognized through sheep die-offs when herds grazed on Halogeton glomeratus, a high-oxalate plant, leading to fatal poisoning.Oxalate in Plants: Functions to bind excess calcium in the soil.Impact on the Body: Plants high in oxalate but low in calcium can contribute to oxalate accumulation, this leads to binding calcium in the blood, creating calcium oxalate crystals and acute renal calculi. Chronic inflammation from excess oxalate deposition leads to CKD progression.High-Oxalate Foods: Spinach, Swiss chard, rhubarb, cashews. Everything in moderation!Practical Advice for Clinicians & Patients on Herbal Medicine Use – 1:00:00Resources for identifying nephrotoxic herbal productsTalk to your patients non judgmentally, open conversations, discuss efficacy (or lack there of, see resources below) and safetyHerbal medicines are not FDA approved and may not contain what they claim toHerbals may not all be safe: Josh King Discovering Contaminants– 1:01:11Wrap up– 1:08Key Takeaways:Aristolochic acid is a direct nephrotoxin, associated with progressive kidney damage and urothelial cancers.Black licorice toxicity results from...

The FiltrateJoel TopfSwapnil HiremathAC GomezSopia AmbrusoNayan AroraSpecial Guests Michelle Rheault, Director, Division of Pediatric Nephrology, Professor of MedicineTiffany Caza, Nephropathologist, Scientist and self-described Freely Filtered fan girlEditing bySimon Topf and Sophia AmbrusoShow Notes10. Healthcare Cyberattacks9. ApoE in C3 glomerulonephropathy8. Workforce woes in Adult and Pediatric Nephrology7. Hyponatremia correction meta-analysis6. Microvascular inflammation increases risk of graft loss - in all of its forms5. Xenotransplantation4. KDIGO CKD Guidelines3. Hypertension control trials (ESPRIT, BPROAD)2. The Renaissance of IgAN: IgAN treatment trials1. FLOW: GLP-1 RAs in CKD

On this podcast episode of the top 200 drugs, I'm covering liraglutide, folic acid, clotrimazole, empagliflozin, and semaglutide. Liraglutide is a GLP-1 agonist that can be used for weight loss as well as diabetes. The most common adverse effect of this medication is nausea. Folic acid is a commonly used supplement in pregnancy as well as in those patients taking methotrexate. Deficiency of folic acid can lead to anemia. Clotrimazole is an antifungal agent. It is mostly used for topical purposes such as athlete's foot and vaginal yeast infections. Empagliflozin was originally developed as a diabetes medication but can be helpful in patients with heart failure and CKD. I discuss this in greater detail in the podcast. Semaglutide is another GLP-1 agonist that is used for diabetes care as well as weight loss. The formulation used for diabetes is Ozempic while the weight loss product is Wegovy.